Follow
Marina Kirkitadze
Marina Kirkitadze
Sanofi Pasteur Ltd
Verified email at sanofi.com
Title
Cited by
Cited by
Year
Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways
G Bitan, MD Kirkitadze, A Lomakin, SS Vollers, GB Benedek, DB Teplow
Proceedings of the National Academy of Sciences 100 (1), 330-335, 2003
16222003
Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis
MD Kirkitadze, MM Condron, DB Teplow
Journal of molecular biology 312 (5), 1103-1119, 2001
8412001
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies
MD Kirkitadze, G Bitan, DB Teplow
Journal of neuroscience research 69 (5), 567-577, 2002
7352002
Structure and flexibility of the multiple domain proteins that regulate complement activation
MD Kirkitadze, PN Barlow
Immunological reviews 180 (1), 146-161, 2001
2642001
Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering
W Yong, A Lomakin, MD Kirkitadze, DB Teplow, SH Chen, GB Benedek
Proceedings of the National Academy of Sciences 99 (1), 150-154, 2002
2542002
Differential scanning calorimetry—A method for assessing the thermal stability and conformation of protein antigen
IB Durowoju, KS Bhandal, J Hu, B Carpick, M Kirkitadze
JoVE (Journal of Visualized Experiments), e55262, 2017
1502017
Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
MD Kirkitadze, A Kowalska
Acta Biochimica Polonica 52 (2), 417-423, 2005
1242005
Demonstration of a tandem pair of complement protein modules in GABAB receptor 1a
E Hawrot, Y Xiao, Q Shi, D Norman, M Kirkitadze, PN Barlow
FEBS letters 432 (3), 103-108, 1998
861998
Independently melting modules and highly structured intermodular junctions within complement receptor type 1
MD Kirkitadze, M Krych, D Uhrin, DTF Dryden, BO Smith, A Cooper, ...
Biochemistry 38 (22), 7019-7031, 1999
551999
Central modules of the vaccinia virus complement control protein are not in extensive contact
MD KIRKITADZE, C HENDERSON, NC PRICE, SM KELLY, NP MULLIN, ...
Biochemical Journal 344 (1), 167-175, 1999
521999
Process analytical technologies–advances in bioprocess integration and future perspectives
G Gerzon, Y Sheng, M Kirkitadze
Journal of Pharmaceutical and Biomedical Analysis 207, 114379, 2022
502022
Structural properties of α-fetoprotein from human cord serum: the protein molecule at low pH possesses all the properties of the molten globule
VN Uversky, MD Kirkitadze, NV Narizhneva, SA Potekhin, ...
FEBS letters 364 (2), 165-167, 1995
481995
Ligand-free form of human α-fetoprotein: evidence for the molten globule state
VN Uversky, NV Narizhneva, TV Ivanova, MD Kirkitadze, AY Tomashevski
FEBS letters 410 (2-3), 280-284, 1997
461997
The herpes simplex virus triplex protein, VP23, exists as a molten globule
MD Kirkitadze, PN Barlow, NC Price, SM Kelly, CJ Boutell, FJ Rixon, ...
Journal of virology 72 (12), 10066-10072, 1998
451998
A direct interaction between Transforming Growth Factor (TGF)-βs and Amyloid-β protein affects fibrillogenesis in a TGF-βReceptor-independent manner
DD Mousseau, S Chapelsky, G De Crescenzo, MD Kirkitadze, J Magoon, ...
Journal of Biological Chemistry 278 (40), 38715-38722, 2003
342003
Co-operativity between modules within a C3b-binding site of complement receptor type 1
MD Kirkitadze, DTF Dryden, SM Kelly, NC Price, X Wang, M Krych, ...
FEBS letters 459 (1), 133-138, 1999
261999
Aluminum phosphate vaccine adjuvant: analysis of composition and size using off-line and in-line tools
C Mei, S Deshmukh, J Cronin, S Cong, D Chapman, N Lazaris, ...
Computational and structural biotechnology journal 17, 1184-1194, 2019
182019
Nuclear magnetic resonance (NMR) study for the detection and quantitation of cholesterol in HSV529 therapeutic vaccine candidate
R Khatun, H Hunter, W Magcalas, Y Sheng, B Carpick, M Kirkitadze
Computational and Structural Biotechnology Journal 15, 14-20, 2017
182017
27Al and 31P NMR spectroscopy method development to quantify aluminum phosphate in adjuvanted vaccine formulations
R Khatun, HN Hunter, Y Sheng, BW Carpick, MD Kirkitadze
Journal of Pharmaceutical and Biomedical Analysis 159, 166-172, 2018
162018
Identity, structure and compositional analysis of aluminum phosphate adsorbed pediatric quadrivalent and pentavalent vaccines
K Kalbfleisch, S Deshmukh, C Mei, M Ore, W Williams, I Durowoju, ...
Computational and Structural Biotechnology Journal 17, 14-20, 2019
142019
The system can't perform the operation now. Try again later.
Articles 1–20